Name | licoisoflavone A |
Synonyms | Phaseoluteone licoisoflavone A Licoisoflavone A,phaseoluteone 2',4',5,7-Tetrahydroxy-3'-(3,3-dimethylallyl)isoflavone 3-[2,4-Dihydroxy-3-(3-methyl-2-butenyl)phenyl]-5,7-dihydroxy-4H-1-benzopyran-4-one 4H-1-Benzopyran-4-one, 3-[2,4-dihydroxy-3-(3-methyl-2-buten-1-yl)phenyl]-5,7-dihydroxy- |
CAS | 66056-19-7 |
Molecular Formula | C20H18O6 |
Molar Mass | 354.35 |
Density | 1.424±0.06 g/cm3(Predicted) |
Boling Point | 635.7±55.0 °C(Predicted) |
Solubility | Almost insoluble (0.015g/L) (25°C) |
Appearance | Powder |
pKa | 6.35±0.20(Predicted) |
Storage Condition | 2-8℃ |
MDL | MFCD04039831 |
Reference Show more | 1. [IF=3.361] Lailai Li et al."Development of a dual screening strategy to identify pro-angiogenic compounds from natural products: application on Tongmai Yangxin Pills."Rsc Adv. 2016 Dec;6(116):115308-115316 2. [IF=4.268] Rui Guo et al."High content screening identifies licoisoflavone A as a bioactive compound of Tongmaiyangxin Pills to restrain cardiomyocyte hypertrophy via activating Sirt3."Phytomedicine. 2020 Mar;68:153171 |
Plant Source: | licorice |
biological activity | Licoisoflavone A, an isoflavone compound, is mainly derived from glycyrhiza uralensis Fisch.. Licoisoflavone A inhibits lipid peroxidation with an IC50 of 7.2 μm. |